Do you remember what the Morning Mayor used to say? Every brand new day should be unwrapped like a precious gift. So go ahead, open yours. And after you do so, grab a cup of something refreshing and take a peek at these…
Baxter Says Heparin Legal Costs Are Insignificant (The Chicago Tribune)
Roche Targets Diabetes To [...]

The pharmaceutical industry is taking a tough line in negotiations on drug pricing, offering to cut the $20 billion National Health Service bill for prescription medsl by roughly half the amount sought by the government, The Daily Telegraph writes.
In secret negotiations, industry leaders have offered to cut the price of patented drugs by under 5 [...]

AstraZeneca’s Tony Zook ran into a lovefest the other day. The Wilmington Rotary Club serenaded the drugmaker’s US ceo with a song they warbled to the tune of Mary Poppins’ “A Spoonful of Sugar” at a luncheon Thursday. But perhaps the lyrics should have been ‘a big bucket of money helps the conflicted professor get [...]

The industry’s trade group has launched its strongest attack to date on the government, accusing it of damaging the integrity of the UK’s business environment by renegotiating the drug pricing mechanism halfway through the current five-year period, The Daily Telegraph reports.
“The decision dented business confidence and the reaction from our global head offices moved [...]

The drugmaker is urging Congress to revive a program for those who want to voluntarily submit their television commercials for regulatory review, according to a letter provided to Reuters. Congress created the program last year but it has not taken effect, and lawmakers failed to give the FDA full authority to collect and spend industry [...]

The University of Cincinnati will increase scrutiny on psychiatry professor Melissa DelBello for failing to report all corporate research money she received from AstraZeneca during the last decade, The Cincinnati Enquirer reports. DelBello now has to review all her industry interactions with her department chairman, UC vp of research Sandra Degen tells the paper.
DelBello’s teaching [...]

The sun is shining brightly on the Pharmalot corporate campus this morning. As we ready our daily cup of stimulation, we are also readying more interesting items. Meanwhile, though, it is time to catch up. So grab your own cup and, before you head into another meeting or hunker down to meet that deadline, take [...]

This looks like a win-win, at least for the drugmakers. For AstraZeneca, the deal means a generic version of its best-selling ulcer med, which racked up $5.2 billion in sales last year, won’t appear in pharmacies this week. That’s when a 30-month stay barring a generic would have expired. “The agreement allows us to spend [...]

Good to see you again. We hope the start of your week went well. As always, there is much to do. We expect to have an interesting item for your later. Meanwhile, we must hurry one of the short people off to school and tend to the official Pharmalot mascot - our pooch. So please [...]

And why not? The US dollar is playing how-low-can-you-go and drugmakers are distracted as they scramble to cut costs. “It’s like the Manhattan real estate market,” David Webster of Webster Consulting, tells Reuters. “What keeps it afloat are the Japanese and Europeans or whoever seems to be making money worldwide and whoever has a strong [...]